Search

everythinglearnresearchcommunity

for

Search:↓

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Belatacept may be a promising treatment for alopecia areata.

Different autoantibody groups in pediatric SLE are linked to specific symptoms and disease outcomes.

IMA may indicate oxidative stress in skin and hair disorders, but more research is needed.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

A new one-step test can quickly identify skin cancer during surgery.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

Four antibodies were developed to help study hair follicle cell differentiation.

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

Serum IMA levels don't help diagnose AGA but may indicate its severity.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

IMA and IMA/albumin levels don't predict alopecia areata severity.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Immunological treatment improved both neuropathy and alopecia.

A 5 cm hair sample can reveal blood type and keratin type for forensic use.

The study suggests that complement activation, not immunoglobulins, may be important in erythema nodosum leprosum.

The modified staining method can determine the ABO blood group of hair samples accurately.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Immunofluorescence tomography is a cost-effective method for creating detailed 3-D images of tissues.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

SH-SY5Y cell lysate is effective for diagnosing Satoyoshi syndrome.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.